MEDIFAST INC (MED) Updates FY17 Earnings Guidance
MEDIFAST INC (NYSE:MED) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.05-$2.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.02. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $288.65 million.MEDIFAST INC also updated its Q3 guidance to $0.48-$0.51 EPS.
Separately, Sidoti cut shares of MEDIFAST INC from a buy rating to a neutral rating in a research note on Tuesday, May 2nd.
Shares of MEDIFAST INC (NYSE MED) traded up 4.86% during trading on Tuesday, hitting $44.21. 135,683 shares of the stock traded hands. MEDIFAST INC has a 52-week low of $34.76 and a 52-week high of $47.35. The firm has a market cap of $527.29 million, a price-to-earnings ratio of 26.96 and a beta of 0.48. The stock has a 50 day moving average of $41.69 and a 200 day moving average of $43.12.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 9th. Investors of record on Friday, June 23rd will be given a $0.32 dividend. The ex-dividend date of this dividend is Wednesday, June 21st. This represents a $1.28 dividend on an annualized basis and a yield of 2.90%. MEDIFAST INC’s dividend payout ratio is currently 77.58%.
MEDIFAST INC Company Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Receive News & Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with MarketBeat.com's FREE daily email newsletter.